Vertex Pharmaceuticals Incorporated (VRTX)
Chart Events
Performance Outlook
| Previous Close | 221.10 |
| Open | 222.34 |
| Bid | 219.40 x 800 |
| Ask | 221.99 x 900 |
| Day's Range | 219.24 - 222.77 |
| 52 Week Range | 202.57 - 306.08 |
| Volume | 1,917,605 |
| Avg. Volume | 2,094,366 |
| Market Cap | 56.783B |
| Beta (5Y Monthly) | 0.68 |
| PE Ratio (TTM) | 21.32 |
| EPS (TTM) | 10.29 |
| Earnings Date | Apr 27, 2021 - May 03, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 285.42 |
- Motley Fool
The Growth Stock Sale of 2021 Has Arrived: 3 Stocks to Buy Now
For the past 12 years, growth stocks have run absolute circles around value stocks. Borrowing rates have continued to push lower and, for much of the past 12 years, the Federal Reserve has maintained a dovish stance with regard to monetary policy. In short, growth stocks have had cheap access to capital with which to innovate, hire, and even acquire other businesses.
- Motley Fool
A Star-Laden Biotech SPAC Worth Considering
In this video from Motley Fool Live, recorded on March 22, Fool.com contributors Brian Orelli and Keith Speights discuss the prospects for Revolution Health Acquisition Corp. (NASDAQ: REVH.U). The healthcare-focused special purpose acquisition company (SPAC) is sponsored by ARCH Ventures and General Catalyst and has some solid leadership at the helm, including former CEO of Vertex (NASDAQ: VRTX) Jeffrey Leiden who serves as the SPAC's chairman.
- Motley Fool
3 Cathie Wood Stocks You Can Buy at a Bargain Right Now
When Cathie Wood talks, investors listen. The founder of Ark Invest has successfully predicted stock market stars -- one of her top holdings is Tesla. Now, here's some great news for all of us who want to follow this investment superstar's lead: Right now, you can buy three of the biggest holdings in her Ark Genomic Revolution ETF at a bargain.
